The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
MJFF Research Grant, 2011Generation of Monoclonal and Polyclonal Antibodies against LRRK1
Objective/Rationale:
There is great excitement that drugs targeting an enzyme called LRRK2 may have utility in the treatment of Parkinson’s disease. Some companies are attempting to develop LRRK2... -
MJFF Research Grant, 2011Generation of Monoclonal and Polyclonal Antibodies Against Aggregated Forms of Alpha-Synuclein
Objective/Rationale:
The aggregation of alpha-synuclein plays a pivotal role in the development of Parkinson’s disease. This subproject focuses on supporting the MJFF initiative of generating... -
MJFF Research Grant, 2011Implementation of PD GWAS meta-analysis results on the PDGene database
Objective/Rationale:
The goal of this proposal is to analyze all available Parkinson’s disease (PD) genomewide association study (GWAS) datasets so that we can identify gene variants associated with... -
MJFF Research Grant, 2011Axonopathy induced by overexpression of human -synuclein in the rat nigrostriatal dopamine system
Objective/Rationale:
Observations made in brains from patients with Parkinson’s disease indicate that the disease may start at the level of the axons and that loss of the affected neurons occur later... -
Rapid Response Innovation Awards, 2011Blood-Brain Barrier Modification Using Heterotopic Nasal Mucosal Grafting for Enhanced Symptoms & Side Effects and Macromolecular Disease Modifying Drug Delivery in Parkinson's Disease
Objective/Rationale:
One of the most significant problems in the treatment of Parkinson’s disease is the inability to provide continuous and high molecular weight drug delivery to the central nervous... -
LEAPS, 2011Supplement to 'Discovery of mGluR4 Potentiators for Symptoms & Side Effects and Disease-Modifying Treatment of PD'
Promising Outcomes of Original Grant:
Activation or potentiation of metabotropic glutamate receptor 4 (mGluR4) is a promising new strategy for both Symptoms & Side Effects and disease-modifying...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.